Our purpose was to evaluate the possible roles of these two molecular markers, fascin and CD44, in the invasive and metastatic behavior of endometrioid carcinoma and to analyse their association with clinicopathological features. The gene discussed is FSCN1; the disease is endometrioid adenocarcinoma.